SEARCH:   Advanced

Blood, 15 May 2006, Vol. 107, No. 10, pp. 3976-3982. Prepublished online as a Blood First Edition Paper on January 19, 2006; DOI 10.1182/blood-2005-11-4551. This Article Abstract Full Text (PDF) All Versions of this Article: 2005-11-4551v1 107/10/3976    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Arnold, J. Articles by Green, P. L. Search for Related Content PubMed PubMed Citation Articles by Arnold, J. Articles by Green, P. L. Related Collections Hematopoiesis and Stem Cells Immunobiology Related Article in Blood Online Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  IMMUNOBIOLOGY Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1 Joshua Arnold, Brenda Yamamoto, Min Li, Andrew J. Phipps, Ihab Younis, Michael D. Lairmore, and Patrick L. Green From the Departments of Veterinary Biosciences and Molecular Virology Immunology, and Medical Genetics, Center for Retrovirus Research, Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH.    Abstract Top Abstract Introduction Materials and methods Results Discussion References   Natural antisense viral transcripts have been recognized in retroviruses, including human T-cell leukemia virus type 1 (HTLV-1), HIV-1, and feline immunodeficiency virus (FIV), and have been postulated to encode proteins important for the infection cycle and/or pathogenesis of the virus. The antisense strand of the HTLV-1 genome encodes HBZ, a novel nuclear basic region leucine zipper (b-ZIP) protein that in overexpression assays down-regulates Tax oncoprotein-induced viral transcription. Herein, we investigated the contribution of HBZ to HTLV-1–mediated immortalization of primary T lymphocytes in vitro and HTLV-1 infection in a rabbit animal model. HTLV-1 HBZ mutant viruses were generated and evaluated for viral gene expression, protein production, and immortalization capacity. Biologic properties of HBZ mutant viruses in vitro were indistinguishable from wild-type HTLV-1, providing the first direct evidence that HBZ is dispensable for viral replication and cellular immortalization. Rabbits inoculated with irradiated cells expressing HTLV-1 HBZ mutant viruses became persistently infected. However, these rabbits displayed a decreased antibody response to viral gene products and reduced proviral copies in peripheral blood mononuclear cells (PBMCs) as compared with wild-type HTLV-1–infected animals. Our findings indicated that HBZ was not required for in vitro cellular immortalization, but enhanced infectivity and persistence in inoculated rabbits. This study demonstrates that retroviruses use negative-strand–encoded proteins in the establishment of chronic viral infections.    Introduction Top Abstract Introduction Materials and methods Results Discussion References   Human T-cell leukemia virus type 1 (HTLV-1) infection causes adult T-cell leukemia/lymphoma and is associated with a variety of lymphocyte-mediated diseases.1 Although infected subjects develop a vigorous and sustained immune response against the virus, infection is typically lifelong. The positive sense RNA genome of HTLV-1 encodes the typical retroviral structural and enzymatic genes Gag, Pol, and Env, the positive regulatory gene products Tax and Rex, and several accessory gene products, p12I, p27I, p13II, and p30II, which are important for viral infectivity and persistence in vivo.2-4 Tax, the transcriptional activator, is an important modulator of both viral and cellular gene expression,5 and its expression is essential for HTLV-mediated cellular transformation of T lymphocytes.6-8 Tax transactivates not only the viral gene promoter, but many host cellular promoters through cAMP response element-binding protein (CREB), nuclear factor B (NF-B), and serum response factor (SRF) pathways.9,10 The stimulation of such pathways by Tax leads to unregulated protein expression and heightened activation in signaling cascades, including Janus kinase/signal transducer and activator of transcription (JAK/STAT), phosphatidylinositol 3-kinase (PI3K), and c-Jun N-terminal kinase (JNK).11-14 It has also been shown that Tax can bind to cyclin-dependent kinase holoenzymes, inactivate tumor supressors such as p53 and discs large protein (DLG), and has the ability to silence cellular checkpoints.15-19 These pleiotropic effects of Tax on the cell have suggested that there may be differences between the initiation and maintenance of transformation.20 The majority of retroviral gene products are encoded by the sense strand of the genome. However, natural antisense viral transcripts have been recognized in retroviruses, including HTLV-1, HIV, and feline immunodeficiency virus (FIV).21-23 The novel HTLV-1 protein HBZ (HTLV-1 b-ZIP factor) is encoded by a minus-strand mRNA that is transcribed by a functional promoter present in the antisense strand of the HTLV-1 proviral genome (Larocca et al21 and Cavanagh et al24). Since exogenously overexpressed HBZ down-regulates Tax-induced HTLV-1 transcription and interacts with and disrupts the DNA binding activity of JunB and c-Jun (AP-1 components),25,26 it has been hypothesized that HBZ may play an important role in HTLV-1 biology by counteracting the effects of Tax at the transcriptional level and attenuating the activation of AP-1. In this study, we evaluated the functional role of HBZ in the context of an infectious molecular clone and determined its contribution to viral-induced immortalization in vitro and viral replication kinetics and persistence in vivo. Our findings indicated that the reported repressive effects of HTLV-1 HBZ on Tax and AP-1 were not sufficient to disrupt the capacity of the virus to immortalize primary T lymphocytes in vitro, but rather, enhanced infectivity and modified virus persistence in vivo.    Materials and methods Top Abstract Introduction Materials and methods Results Discussion References   Cells 293T cells and 729 B cells were maintained in Dulbecco modified Eagle and Iscove medium, respectively. The media were supplemented to contain 10% fetal bovine serum (FBS), 2 mM glutamine, penicillin (100 U/mL), and streptomycin (100 µg/mL). Human peripheral blood mononuclear cells (hPBMCs) were isolated using Ficoll Hypaque (Amersham, Piscataway, NJ) and cultured in RPMI 1640 medium supplemented with 20% fetal bovine serum (FBS), 2 mM glutamine, and antibiotics in the presence or absence of 10 U/mL recombinant human interleukin-2 (IL-2; Roche Applied Biosciences, Indianapolis, IN). The protocol to obtain human blood was approved by The Ohio State University human subjects internal review board. Plasmids The plasmid containing the wild-type HTLV-1 (wtHTLV-1) infectious proviral clone, pACHneo, was used in this study.27,28 HTLV-1HBZLZ was generated by changing the sequence 6760ACTCCA6765 to GCTAGC, which introduced a diagnostic NheI restriction enzyme site that truncates or terminates the HBZ reading frame at amino acid 175 of the published sequence29 (amino acid 172 of the HBZ major transcript24) by deleting the majority of the C-terminal leucine zipper (LZ) region. This mutation did not alter any other known HTLV-1 open reading frames (ORFs). HTLV-1HBZ was generated by introducingaGtoA point mutation (nt 7258) that resulted in termination of the HBZ reading frame at amino acid 11 of the published sequence29 (amino acid 8 of the HBZ major transcript24). This single base mutation is 30 nucleotides 5' to the p13II ATG on the sense strand and resulted in an Arg to Gln amino acid change in the accessory protein p30II. This p30II mutant displays a wild-type phenotype in both the transcriptional and posttranscriptional assays previously used to define p30II function in vitro30,31 (data not shown). HBZ and HBZLZ cDNA expression vectors (pME vector–based) were generated from the ACH proviral clone sequences (based on the HBZ major transcript24). The long terminal repeat 1 (LTR-1)–Luc and thymidine kinase (TK)–Renilla were described previously.30 Transfection, luciferase assay, and detection of viral p19 matrix antigen To measure Tax function, 1.5 x 105 293T cells were transfected using Lipofectamine (Invitrogen, Carlsbad, CA). The amount of DNA was kept constant and was composed of 0.1 µg of LTR-1–Luc reporter and 10 ng TK-Renilla along with 2 µg of an empty plasmid or proviral clones. Cell supernatants (48 hours) were used for p19 enzyme-linked immunosorbent assay (ELISA; Zeptometrix Corporation, Buffalo, NY). Cell pellets were lysed and Tax activity was measured in light units as described previously.27 All experiments were performed independently 3 times in triplicate and the results were normalized for transfection efficiency using Renilla luciferase. Stable 729 transfectants containing proviral clones were isolated as described,27 and cell clones were screened by p19 Gag expression in the cell supernatant by ELISA. DNA preparation and standard PCR DNA was isolated from 729 producer cell lines, immortalized human PBMCs, or infected rabbit PBMCs using PURGENE DNA purification system (Gentra, Minneapolis, MN). DNA (0.5 µg) was subjected to 35-cycle polymerase chain reaction (PCR; 95° for 5 minutes, 95°C for 1 minute, 56°C for 1 minute, and 72°C for 1 minute, followed by 72°C for 10 minutes and held at 4°C). The HTLV-1–specific primer pair 7145GTCAAGCACAGCTTCCTCCTCCTC7168 and 7386GGGGCACCAGTCGCCTTGTACACA7363 was used to amplify a 241–base pair fragment for sequencing to confirm the HBZ mutation. The HTLV-1–specific primer pair H1JA16659 TTATTGCAACCACATCGCCTCCAGCCTCCC6688 and H1JA2 6885AGGAGCGCCGTGAGCGCAAGT6865 was used to amplify a 226–base-pair fragment that was subjected to NheI diagnostic digestion and sequenced to confirm the HBZLZ mutation. RT-PCR and quantitative Taqman real-time RT-PCR RNA was extracted using the RNeasy kit (Quiagen, Valencia, CA) from SLB-1, 729.ACHneo, and 729 uninfected control cells. Total RNA was subjected to 3 consecutive DNase treatments followed by OLIGOTEX polyA+ mRNA isolation (Quiagen). PolyA+ mRNA (25 ng) was subjected to reverse transcriptase (RT)–PCR using the first-strand synthesis kit and the primer HMS6659 TTATTGCAACCACATCGCCTCCAGCCTCCC6688 (1 µM) to generate cDNA from the minus strand HBZ transcript RNA. Duplicate reactions were performed in the presence and absence of RT to control for DNA background/contamination. The cDNAs then were subjected to standard PCR using the HTLV-1–specific primer pair H1JA1 and H1JA2. Human GAPDH was amplified using primers previously described.32 PCR-amplified fragments were separated on a 1% agarose gel and visualized by ethidium bromide staining. Forty cycles of real-time Taqman PCR (Applied Biosystems, Foster City, CA) were conducted to quantitate proviral copy number per cell in infected rabbit PBMCs. Rabbit PBMC DNA was amplified in duplicate using the primers TaxS 7335CGGATACCCAGTCTACGTGTTT7356 and TaxAS 7495CTGAGCCGATAACGCGTCCA7476 and probe (5'-FAM-7456ATCACCTGGGACCCCATCGATGGA7476-TAMARA-3') and final values were averaged. The 25-µL reactions contained 500 ng rabbit PBMC DNA, 100 ng (25 ng/mL) of each primer and probe concentration of 100 pmol/µL. Copy number was determined based on a standard curve generated from duplicate samples of log10 dilutions of a plasmid containing the Tax sequences. The copy number per cell value for a sample was generated based on the estimation that 1 µg PBMC DNA is equivalent to 67 300 cells. Western blot Western blot was performed as described30 using rabbit anti-pHBZ polyclonal antisera (1:500) and goat antirabbit conjugated with horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA). Proteins were visualized using the electrochemiluminescence (ECL) Western blot analysis system (Amersham Biosciences, Piscataway, NJ). Short-term coculture microtiter proliferation and long-term immortalization assays Short-term microtiter proliferation assays were performed as described previously.33 Briefly, 729 HTLV producer cells (200) were irradiated with 100 Gy (10 000 rad) and cocultured with 104 prestimulated PBMCs in the presence of human (h) IL-2 in 96-well round-bottom plates. Wells were enumerated for growth and split 1:4 at weekly intervals. For long-term immortalization assays, 106 irradiated 729 producer cells were cocultivated with 2 x 106 freshly isolated PBMCs with 10 U/mL hIL-2 in 24-well culture plates.34 The presence of HTLV expression was confirmed at weekly intervals by detection of p19 Gag protein in the culture supernatant using an ELISA. Viable cells also were counted by trypan blue exclusion. Cells inoculated with wtHTLV-1 and HTLV-1 HBZ mutant viruses that continued to produce p19 Gag antigen and proliferate 12 weeks after coculture in the presence of exogenous hIL-2 were identified as immortalized. Rabbit inoculation procedure Twelve-week-old specific pathogen–free female New Zealand White rabbits (Hazelton, Kalamazoo, MI) were inoculated via the lateral ear vein with approximately 1 x 107 gamma-irradiated 75 Gy (7 500 rad) 729 viral producer cells or uninfected control cells. At weeks 0, 2, 4, 6, and 8 after inoculation, 10 mL blood was drawn from the central ear artery of each animal. This study protocol was approved by the University Laboratory Animal Resources (ULAR) of The Ohio State University. Serum reactivity to specific viral antigenic determinants was detected using a commercial HTLV-1 Western blot assay (GeneLabs Diagnostics, Singapore). Serum (dilution of 1:400) showing reactivity to Gag (p24 or p19) and Env (gp21 or gp46) antigens was classified as positive for HTLV-1 seroreactivity (data not shown). A commercial ELISA kit (Vironostika HTLV-1 MicroELISA system; BioMerieux, Durham, NC) was used to quantitate HTLV-1 serum antibody. Plasma was diluted 1:12 000 to obtain values in the linear range of the assay and data were expressed as absorbance values. View larger version (48K): [in this window] [in a new window]   Figure 1.. Detection of the HBZ RNA transcript. (A) HBZ transcript was detected in Poly A+ RNA isolated from SLB-1 and 729.HTLV-1, but not 729 uninfected (Uninf), using standard RT-PCR. First-strand synthesis with a specific oligo designed to copy only HTLV-1 antisense RNA containing the HBZ coding sequence was performed in the presence and absence of reverse transcriptase. The 226-bp PCR product was separated on a 2% agarose gel and visualized by ethidium bromide staining. (B) Schematic representation of the complete HTLV-1 proviral genome is shown. LTRs are depicted with their U3, R, and U5 regions. The location of the viral open reading frames and the opposite-strand HBZ are indicated. The reported HBZ coding sequence has been expanded showing the transactivation domain, basic region, and leucine-zipper region, as well as the 2 HBZ truncation mutants generated for this study (HBZLZ and HBZ).      Results Top Abstract Introduction Materials and methods Results Discussion References   The HBZ transcript was detected in HTLV-1–transformed and stably transfected cell lines It was reported previously that the HBZ transcript was present in HTLV-1–infected SLB-1 cells, but in a relatively low quantity compared with tax/rex mRNA.21 In addition, the HBZ protein was detected in the HTLV-1–infected cell line C8166, but could not be detected in MT-2 cells.29 Since our studies make use of the HTLV-1 molecular proviral clone ACH,28 initial experiments were designed to verify the expression of the HBZ mRNA transcript in the HTLV-1 producer cell line 729.ACHneo (referred to as 729.HTLV-1). This cell line produces HTLV-1 that has the capacity to infect and transform human PBMCs.35,36 Poly A+ RNA isolated from SLB-1, 729.HTLV-1, and uninfected 729 cells was subjected to standard RT-PCR in the presence and absence of reverse transcriptase. HBZ mRNA was clearly detected in SLB-1 and 729.HTLV-1, but absent in 729-uninfected cells (Figure 1A). In addition, reactions in which the reverse transcriptase was omitted indicated that no amplified product resulting from DNA contamination was detected. Therefore, the ACH molecular clone produced a minusstrand transcript reported to encode HBZ. View larger version (11K): [in this window] [in a new window]   Figure 2.. Characterization of proviral clones in vitro. 293 T cells (1.5 x 105) were cotransfected with 2 µg wtHTLV-1, HTLV-1HBZ, HTLV-1HBZLZ proviral clones, or negative control DNA along with 0.1 µg LTR-1–Luc and 0.01 µg TK-Renilla. All transfections were performed in triplicate and normalized to TK-Renilla to control for transfection efficiency. Cell lysates or supernatants were harvested 48 hours after transfection. Histograms present the average values from 3 independent experiments; error bars denote (SD). (A) Measure of Tax activity presented as relative luciferase units. (B) Measure of p19 Gag in the cellular supernatants.   Construction and characterization of HTLV-1 HBZ mutant proviral clones Although informative, studies to date investigating the function or activity of HBZ have been performed in overexpression systems outside the context of the entire provirus. In order to determine the role of HBZ in HTLV-1–mediated cellular immortalization in vitro and viral persistence in vivo, we generated 2 mutant proviral clones. HTLV-1HBZLZ has a deletion in the C-terminal leucine zipper that is a key functional domain for b-ZIP proteins and is required for the association of HBZ with CREB-2, JunB, and c-Jun.25,26,29 HTLV-1HBZ has a severely truncated HBZ within the first 10 amino acids (Figure 1B). We first determined whether HBZ mutant proviruses had altered Tax-mediated LTR gene expression. Cotransfection of either HBZ wild-type or HBZ mutant HTLV-1 proviral clones, as a source of Tax, and the LTR-1–Luc reporter revealed no significant difference in LTR-directed gene expression (Figure 2A). Moreover, cells transfected with either HBZ mutant proviral clone produced levels of p19 Gag in the culture supernatant similar to wild-type HTLV-1 (Figure 2B). We next determined the effect of exogenously expressed HBZ on Tax-mediated transcription. Our results indicated that HBZ expressed from a cDNA vector significantly repressed Tax-mediated transcription in a dose-dependent manner (Figure 3A). Importantly, the HBZLZ cDNA expression vector failed to repress Tax-mediated transcription (Figure 3A). In direct correlation, the addition of HBZ, but not HBZLZ, resulted in a dose-dependent reduction of p19 Gag in the supernatant of transfected cells (Figure 3B). Western blot analysis confirmed that the amount of HBZ or HBZLZ protein expressed correlated directly with the amount of plasmid DNA transfected, whereas a control cellular protein, -actin, remained unchanged (Figure 3C). Taken together, these data support previous published work that the leucine zipper is a key functional domain required for protein interaction and transcriptional repression,25,26,29 and also indicates that the repression is not the result of a significant RNA interference (RNAi) effect on Tax/Rex or Gag/Pol. These results are also consistent with the conclusion that either HBZ is not expressed from the proviral clone following transient transfection or that the levels of HBZ expressed from the proviral clone are below the threshold concentration required for a detectable repression of viral transcription. View larger version (14K): [in this window] [in a new window]   Figure 3.. Exogenously expressed HBZ results in dose-dependent repression of Tax-mediated transcription and p19 Gag production. 293T cells (1.5 x 105) were cotransfected with 1 µg wtHTLV-1 proviral clone or negative control DNA, 0.1 µg LTR-1–Luc, and 0.01 µg TK-Renilla, and varying concentrations (0.1-0.4 µg) of HBZ or HBZLZ expression vectors as indicated. (A) Tax function was measured as firefly luciferase activity (RLU indicates relative light units) from LTR-Luc normalized to Renilla luciferase activity. (B) Culture supernatant was collected from cells in panel A and assayed for p19 Gag production by ELISA. (C) Western blot analysis to confirm increasing concentrations of HBZ and HBZLZ used in panels A and B. -actin levels were assessed as a loading control. *Statistically significant dose-dependent reduction of Tax transactivation activity or p19 Gag production. Statistical significance was determined by analysis of variance (ANOVA) followed by Tukey test. The histogram presents the average values from 3 independent experiments; error bars denote SDs.   HBZ repressed viral gene expression in stable viral producer cell clones To determine the capacity of HBZ mutant proviral clones to synthesize viral proteins, direct viral replication, and induce cellular immortalization, stable 729 cell transfectants expressing the proviral clones were isolated and characterized. Each stable transfectant contained complete copies of the provirus with the expected mutations (data not shown). Using Western blot analyses, HBZ was detected in the HTLV-1–transformed cell line SLB-1 and the virus producer cell line 729.HTLV-1. A smaller form of HBZ was detected in 729.HTLV-1HBZLZ consistent with the truncation and as expected, HBZ was not detected in 729.HTLV-1HBZ or in the negative control 729 (Figure 4A). To monitor the production of another viral protein in these mutant stable transfectants, the concentration of p19 Gag in the culture supernatant of several independently isolated cell clones was quantified by ELISA. p19 Gag expression can be variable from independent stable cell clones attributable to chromosomal location of proviral sequences and overall proviral copy number. However, we consistently observed a significant increase in p19 Gag production in cell clones expressing HBZ mutant proviral clones (Figure 4B), which is consistent with the conclusion that in stable cell lines the loss of HBZ function results in increased viral gene expression. View larger version (53K): [in this window] [in a new window]   Figure 4.. HBZ and p19 Gag protein expression in stably transfected cell lines. (A) HBZ protein was detected in stable provirus expressing cell lines by Western blot using a rabbit polyclonal antibody against HBZ. HBZ was not detected in 729 control and 729.HTLV-1HBZ as expected. HBZ polypeptide of the expected molecular weight was detected in SLB-1, 729.HTLV-1, and 729.HTLV-1HBZLZ. (B) HTLV-1 p19 Gag was quantified by ELISA from 3 independently isolated stable 729 transfectants expressing wild-type HTLV-1, HTLV-1HBZ, or HTLV-1HBZLZ. HBZ mutant virus producers expressed statistically greater amounts of p19 Gag than wild-type virus producers, which was consistent with a repressive role of HBZ on viral transcription. p19 Gag production of the 2 mutant virus producers (HTLV-1HBZ and HTLV-1HBZLZ) were not statistically significant. Statistical significance was determined by ANOVA followed by Tukey test. The histogram presents the average values from 3 independent experiments; error bars denote SDs.   HBZ-deficient mutants promoted HTLV-1–induced proliferation and immortalization of PBMCs We next assessed the capacity of the HBZ mutant viruses to immortalize human PBMCs in coculture assays. Freshly isolated human PBMCs cocultured with lethally irradiated 729.HTLV-1, 729.HTLV-1HBZ, or 729.HTLV-1HBZLZ in the presence of 10 U/mL hIL-2 showed very similar progressive growth patterns consistent with the HTLV-1 immortalization process (Figure 5A). We also detected continuous accumulation of p19 Gag in the culture supernatant, indicating viral replication and virion production (Figure 5B). Immortalized PBMCs harbored the expected HTLV-1 sequences, suggesting that viral transmission was responsible for the immortalization of PBMCs (Figure 5C and data not shown). In an effort to obtain a more quantitative measure of the ability of these viruses to infect and immortalize PBMCs, a fixed number of PBMCs were cocultured with different dilutions of virus-producing cells in a 96-well plate assay.33 Since this assay is very stringent, slowly growing or nondividing cells are eliminated very quickly and the percentage of surviving wells is an accurate measure of the immortalization efficiency of viruses. A Kaplan-Meier plot of HTLV-1–induced T-cell proliferation indicated that the percentage of wells containing proliferating lymphocytes was similar between HTLV-1 and HTLV-1 HBZ mutants (Figure 5D). Taken together, our results are consistent with the conclusion that HBZ is not required for efficient infectivity or HTLV-1–mediated immortalization of primary human T lymphocytes in vitro. HTLV-1 HBZ enhanced infectivity and persistence in inoculated rabbits To evaluate the role of HBZ in vivo, we compared the abilities of 729, 729.HTLV-1, 729.HTLV-1HBZ, or 729.HTLV-1HBZLZ cell lines to transmit virus to rabbits, which is an established model of infection and persistence.3,37 Rabbits were inoculated with lethally irradiated cell lines (cell inoculums were equilibrated based on their p19 Gag production) and blood was drawn at biweekly intervals. Antibody response to viral antigens was detected by Western blot in all rabbits inoculated with cells expressing either wild-type HTLV-1 or HBZ mutant viruses, and the antibody titers in the majority of the rabbits increased over the time course of the study (data not shown). Moreover, quantitative comparison of antibody responses between each rabbit was performed using a HTLV-specific ELISA (Figure 6A). Statistical analysis of titers at both 4 and 8 weeks after inoculation revealed a significantly lower antibody response to HTLV-1 antigens in the 729.HTLV-1HBZLZ– and 729.HTLV-1HBZ–inoculated rabbits compared with the wild-type control group. Consistent with our antibody data, HTLV-1 DNA sequences were detected in all wild-type HTLV-1 and HBZ mutant virus–infected rabbits (Table 1). However, quantitative real-time Taqman PCR revealed that as early as 2 weeks after inoculation, and later at 8 weeks after inoculation, proviral loads in rabbits infected with either HBZ mutant virus were lower than rabbits inoculated with wild-type HTLV-1 (Table 1). Proviral loads in both wild-type and HBZ mutant virus–infected rabbits correlated with the observed antibody responses (Figure 6A). Diagnostic DNA PCR analyses and or nucleotide sequencing performed on PBMCs from rabbits 8 weeks after infection indicated that the infected cells contained the expected viral sequences (Figure 6B and data not shown). Taken together, our results indicated that HBZ, while dispensable for HTLV-1 infection, attenuated parameters of virus replication such as antibody response to viral antigens and proviral loads, which were decreased compared with wild-type HTLV-1–infected rabbits. This attenuation is apparent within 2 weeks after inoculation, suggesting that HBZ function is required early for efficient replication and survival in the host. In addition, since HBZ and HBZLZ mutants displayed a similar phenotype in vivo, we concluded that the leucine zipper domain was critical for HBZ functional activity. View this table: [in this window] [in a new window]   Table 1.. Detection and quantification of HTLV-1 DNA in rabbit PBMCs   View larger version (19K): [in this window] [in a new window]   Figure 5.. HTLV-1 T-lymphocyte proliferation and immortalization assays. PBMC (2 x 106) donor cells were cultured with (106) irradiated producer cells as indicated in 24-well plates. (A) Representative growth curve is presented showing cell viability at weekly intervals. The mean and standard deviation of each time point was determined from 3 random independent samples. (B) HTLV-1 gene expression was quantified by detection of Gag protein in the culture supernatant using ELISA. (C) The HTLV-1 genome fragment containing the HBZ coding region was amplified by PCR from DNA of immortalized PBMCs as indicated (HTLV-1HBZLZ DNA was cut by NheI). (D) Prestimulated PBMCs (104) were cocultured with 2000 irradiated 729 stable producer cells in 96-well plates. The Kaplan-Meier plot shows the percentages of proliferating wells as a function of time (weeks). Results indicated that the percentage of wells containing proliferating lymphocytes was similar between wtHTLV-1 and HBZ mutant viruses.   View larger version (34K): [in this window] [in a new window]   Figure 6.. Assessment of HTLV-1 infection in rabbits. (A) Antibody response against HTLV-1 from each rabbit was measured by anti–HTLV-1 ELISA assay, using both HTLV-1 Gag and envelope proteins as antigens. Each dot represents the absorbance value of a single inoculated rabbit at 0, 2, 4, 6, and 8 weeks after inoculation within each group. Inoculum as indicated at bottom includes 729.HTLV-1 (n = 5), 729.HTLV-1HBZ (n = 6), 729.HTLV-1HBZLZ (n = 6), or 729/media (n = 2). The horizontal line represents the average of the rabbit group at each weekly time point and the dotted line represents 3 times the standard deviation of uninfected control values. (B) The HTLV-1 genome fragment containing the HBZ coding region was amplified by PCR from DNA of PBMCs from a representative of at least 1 rabbit of each group (week 8 after inoculation). The expected HBZ mutations in rabbit PBMCs were confirmed using the diagnostic restriction enzyme NheI for HTLV-1HBZLZ and further confirmed by nucleotide sequencing (data not shown).      Discussion Top Abstract Introduction Materials and methods Results Discussion References   The role of the novel HTLV-1–negative-strand gene product, HBZ, in viral replication and/or pathogenesis remains to be defined. Exogenously overexpressed HBZ has been shown to interact with several cellular transcriptional factors such as the CREB-2,25 JunD,38 JunB, and c-Jun25,26 and is a negative regulator of Tax-mediated HTLV-1 transcription.29 In the present study, site-directed mutations were introduced in an infectious molecular clone of HTLV-1 to severely truncate HBZ or delete the carboxy terminal leucine-zipper domain, while maintaining the ability to express other viral gene products. We examined the expression of HBZ and determined its biologic significance for the immortalization of primary human T lymphocytes in vitro and viral persistence in vivo. We showed that the HBZ antisense viral transcript (Figure 1A) and protein (Figure 4A) were expressed from the ACH HTLV-1 molecular proviral clone. Consistent with a previous report,21 quantitative real-time RT-PCR revealed that, although variable with each individual cell line, the level of HBZ mRNA transcription was approximately 20- to 50-fold lower than the abundant tax/rex mRNA (data not shown). We observed that in the context of a proviral clone, the repressive effects of HBZ on Tax transcription were not apparent following transient transfection (Figure 2A), but confirmed that overexpression of HBZ from a cDNA plasmid down-regulated Tax-mediated viral transcription (Figure 3A). We further demonstrated that the repressive effects of HBZ on Tax-mediated transcription were detectable in cell lines stably harboring the proviral clone (Figure 4B). Therefore, we speculate that HBZ gene expression is temporally regulated and not expressed following transient proviral DNA plasmid delivery or that a threshold level of HBZ is required for the repressive activity. Data from our short-term proliferation and immortalization assays indicated that the reported repressive effects of the HTLV-1 HBZ on Tax and AP-125,26 were not sufficient to disrupt the capacity of the virus to infect, induce proliferation, and/or immortalize primary T lymphocytes in vitro (Figure 5A,D). Therefore, similar to the HTLV-1 pX open reading frame (ORF) I and II encoded accessory proteins,39,40 HBZ appears to be dispensable for efficient viral infectivity, replication and primary T-lymphocyte immortalization capacity in vitro. Based on the efficient infectivity and immortalization of cells in vitro and our findings that 729.HTLV-1HBZ– and 729.HTLV-1HBZLZ–inoculated rabbits became infected with HTLV-1, we hypothesized that the biologic function of HBZ and its role in HTLV-1 biology is not likely during the early phase of viral infection. However, future experiments designed to quantitatively assess viral infectivity of rabbits at 1 to 2 days after inoculation will ultimately be required to definitively rule out an early block in infection in vivo. It is clear that soon after inoculation, some parameters of viral replication are attenuated in HTLV-1 HBZ mutant virus–infected animals. We begin to observe a reduction in proviral load as early as 2 weeks after inoculation compared with the wild-type virus (Table 1). By 8 weeks HBZ mutant–inoculated rabbits show a significant reduction in antibody response to viral gene products and a 15- to 20-fold drop in proviral load compared with the wild-type virus (Figure 6A, Table 1). Combined with the data that HTLV-1 HBZ repressed Tax-mediated transcription and attenuated AP-1 activity, we speculated that HBZ might function in concert with other viral gene products to tightly regulate viral replication and/or influence the infected lymphocyte to ultimately promote infected cell survival, viral spread, and assist in establishment of persistent infection. Interestingly, HBZ's repressive function and potential contribution to HTLV-1 replication or leukemogenesis may be somewhat analogous to what has been reported for the HTLV-1 p30II accessory protein.41 p30II selectively increases key regulatory genes, influences T-cell signaling, apoptosis, and the cell cycle, but overall represses cellular gene expression. Many of these affects appear to counteract the HTLV-1 oncoprotein Tax. It remains a possibility that HBZ and p30II work synergistically to ultimately modulate viral and cellular gene expression during different stages of the infection to promote virus survival. Since HBZ is expressed from an antisense transcript it might be predicted to result in a short interfering RNA (siRNA) or double-strand RNA (dsRNA) effect, ultimately resulting in a nucleic acid–based adaptive immunity. Recent evidence indicates that HIV-1 encodes viral siRNA precursors in its genome and provokes an RNA-silencing response.42 However, a domain of the HIV-1 Tat protein has been identified which suppresses the production of siRNAs and the cell's RNA-silencing defense.42 Thus far, there is no evidence to suggest that the HBZ antisense transcript induces RNAi. On the contrary, data presented in Figure 4A and 4B indicates that the HBZLZ expression vector, which makes the same RNA transcript as the HBZ vector with the exception of 4 nucleotide changes, fails to repress Tax activity and p19 Gag protein expression. However, it still remains a possibility that the HBZ antisense transcript may have an RNAi effect on the ORF I– or II–encoded proteins, but this is currently difficult to test since these proteins are not expressed at detectable levels from the provirus. It is exciting to speculate that HTLV-1, like HIV-1, may also have a suppressor of RNA silencing, but further studies are required to determine if the virus encodes such an activity. In summary, our work provides the first demonstration that retroviruses use novel negative-strand gene products to enhance virus replication in vivo. Further studies are warranted to explore the effects of HTLV-1 HBZ on repression of viral transcription and its potential role in innate, cytotoxic T-cell, and natural killer (NK) cell immune surveillance. More broadly, our data elucidate future directions for studies to understand the role of negative-strand–encoded proteins in retroviral-mediated disease and offer new targets for therapy to disrupt virus replication in infected subjects.    Acknowledgements   We thank Li Xie for technical assistance, Kate Hayes for editorial comments on the manuscript, and Tim Vogt for figure preparations.    Footnotes   Submitted November 17, 2005; accepted January 7, 2006. Prepublished online as Blood First Edition Paper, January 19, 2006; DOI 10.1182/blood-2005-11-4551. Supported by a grant from the National Institutes of Health (AI064440). An Inside Blood analysis of this article appears at the front of this issue. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: Patrick L. Green, The Ohio State University, 1925 Coffey Rd, Columbus, OH 43210; e-mail: green.466{at}osu.edu.    References Top Abstract Introduction Materials and methods Results Discussion References   Green PL, Chen ISY. Human T-cell leukemia virus types 1 and 2. In: Knipe DM, Howley P, Griffin D, Lamb R, Martin M, Straus S, eds. Virology. 4th ed. Philidelphia, PA: Lippincott Williams & Wilkins; 2001: 1941-1969. Bartoe JT, Albrecht B, Collins ND, et al. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol. 2000;74: 1094-1100.[Abstract/Free Full Text] Collins ND, Newbound GC, Albrecht B, Beard J, Ratner L, Lairmore MD. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood. 1998;91: 4701-4707.[Abstract/Free Full Text] Silverman LR, Phipps AJ, Montgomery A, Ratner L, Lairmore MD. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol. 2004;78: 3837-3845.[Abstract/Free Full Text] Wycuff DR, Marriott SJ. The HTLV-1 Tax oncoprotein: hypertasking at the molecular level. Front Biosci. 2005;10: 620-642.[Medline] [Order article via Infotrieve] Grassmann R, Berchtolds S, Radant I, et al. Role of the human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol. 1992;66: 4570-4575.[Abstract/Free Full Text] Robek MD, Ratner L. Immortalization of CD4+ and CD8+ T-lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol. 1999;73: 4856-4865.[Abstract/Free Full Text] Ross TM, Pettiford SM, Green PL. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol. 1996;70: 5194-5202.[Abstract/Free Full Text] Azran I, Schavinsky-Khrapunsky Y, Aboud M. Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology. 2004;1: 20.[CrossRef][Medline] [Order article via Infotrieve] Jeang KT. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B. Cytokine Growth Factor Rev. 2001;12: 207-217.[CrossRef][Medline] [Order article via Infotrieve] Jin DY, Teramoto H, Giam CZ, Chun RF, Gutkind JS, Jeang KT. A human suppressor of c-Jun N-terminal kinase 1 activation by tumor necrosis factor alpha. J Biol Chem. 1997;272: 25816-25823.[Abstract/Free Full Text] Xu X, Kang SH, Heidenreich O, Brown DA, Nerenberg MI. Sequence requirements of ATF2 and CREB binding to the human T-cell leukemia virus type 1 LTR R region. Virology. 1996;218: 362-371.[CrossRef][Medline] [Order article via Infotrieve] Liu Y, Wang Y, Yamakuchi M, et al. Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax. Oncogene. 2001;20: 2514-2526.[CrossRef][Medline] [Order article via Infotrieve] Migone TS, Lin JX, Cereseto A, et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science. 1995;269: 79-81.[Abstract/Free Full Text] Lee SS, Weiss RS, Javier RT. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A. 1997; 94: 6670-6675.[Abstract/Free Full Text] Hatta Y, Koeffler HP. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). Leukemia. 2002;16: 1069-1085.[CrossRef][Medline] [Order article via Infotrieve] Hangaishi A, Ogawa S, Imamura N, et al. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood. 1996;87: 4949-4958.[Abstract/Free Full Text] Haller K, Wu Y, Derow E, Schmitt I, Jeang KT, Grassmann R. Physical interaction of human T-cell leukemia virus type 1 tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol. 2002;22: 3327-3338.[Abstract/Free Full Text] Haller K, Ruckes T, Schmitt I, Saul D, Derow E, Grassmann R. Tax-dependent stimulation of G1 phase-specific cyclin-dependent kinases and increased expression of signal transduction genes characterize HTLV type 1-transformed T cells. AIDS Res Hum Retroviruses. 2000;16: 1683-1688.[CrossRef][Medline] [Order article via Infotrieve] Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 2005;24: 5976-5985.[CrossRef][Medline] [Order article via Infotrieve] Larocca D, Chao LA, Seto MH, Brunck TK. Human T-cell leukemia virus minus strand transcription in infected cells. Biochem Biophys Res Commun. 1989;163: 1006-1013.[CrossRef][Medline] [Order article via Infotrieve] Briquet S, Richardson J, Vanhee-Brossollet C, Vaquero C. Natural antisense transcripts are detected in different cell lines and tissues of cats infected with feline immunodeficiency virus. Gene. 2001;267: 157-164.[CrossRef][Medline] [Order article via Infotrieve] Vanhee-Brossollet C, Thoreau H, Serpente N, D'Auriol L, Levy JP, Vaquero C. A natural antisense RNA derived from the HIV-1 env gene encodes a protein which is recognized by circulating antibodies of HIV+ individuals. Virology. 1995; 206: 196-202.[CrossRef][Medline] [Order article via Infotrieve] Cavanagh M-H, Landry S, Audet B, et al. HTLV-I antisense transcripts initiating in the 3' LTR are alternatively spliced and polyadenylated. Retrovirology. 2006;3: 15.[CrossRef][Medline] [Order article via Infotrieve] Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard J. HBZ factor of HTLV-1 dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem. 2003;278: 43620-43627.[Abstract/Free Full Text] Matsumoto J, Ohshima T, Isono O, Shimotohno K. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene. 2005;24: 1001-1010.[CrossRef][Medline] [Order article via Infotrieve] Ye J, Sileverman L, Lairmore MD, Green PL. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro. Blood. 2003;102: 3963-3969.[Abstract/Free Full Text] Kimata JT, Wong FH, Wang JJ, Ratner L. Construction and characterization of infectious human T-cell leukemia virus type I molecular clones. Virology. 1994;204: 656-664.[CrossRef][Medline] [Order article via Infotrieve] Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard J. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol. 2002;76: 12813-12822.[Abstract/Free Full Text] Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL. Repression of human T-cell leukemia virus type 1 and 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol. 2004;78: 11077-11083.[Abstract/Free Full Text] Zhang W, Nisbet JW, Bartoe JT, Ding W, Lairmore MD. Human T-lymphotropic virus type 1 p30II functions as a transcription factor and differentially modulates CREB-responsive promoters. J Virol. 2000;74: 11270-11277.[Abstract/Free Full Text] Kusuhara K, Anderson M, Pettiford SM, Green PL. Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs. J Virol. 1999;73: 8112-8119.[Abstract/Free Full Text] Persaud D, Munoz JL, Tarsis SL, Parks ES, Parks WP. Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay. J Virol. 1995;69: 6297-6303.[Abstract] Green PL, Ross TM, Chen ISY, Pettiford S. Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. J Virol. 1995;69: 387-394.[Abstract] Anderson MD, Ye J, Xie L, Green PL. Transformation studies with a human T-cell leukemia virus type 1 molecular clone. J Vir Meth. 2004;116: 195-202. Ye J, Xie L, Green PL. Tax and overlapping Rex sequences do not confer the distinct transformation tropisms of HTLV-1 and HTLV-2. J Virol. 2003;77: 7728-7735.[Abstract/Free Full Text] Collins ND, Newbound GC, Ratner L, Lairmore MD. In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1. J Virol. 1996;70: 7241-7246.[Abstract/Free Full Text] Thebault S, Basbous J, Hivin P, Devaux C, Mesnard JM. HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett. 2004;562: 165-170.[CrossRef][Medline] [Order article via Infotrieve] Derse D, Mikovits J, Ruscetti F. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology. 1997;237: 123-128.[CrossRef][Medline] [Order article via Infotrieve] Robek M, Wong F, Ratner L. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol. 1998;72: 4458-4462.[Abstract/Free Full Text] Michael B, Nair AM, Hiraragi H, et al. Human T lymphotropic virus type 1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology. 2004;1: 39.[CrossRef][Medline] [Order article via Infotrieve] Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity. 2005;22: 607-619.[CrossRef][Medline] [Order article via Infotrieve] CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? Related Article in Blood Online: HTLV-1 HBZ: stop making sense Gerold Feuer Blood 2006 107: 3813-3814. [Full Text] [PDF] This article has been cited by other articles: M. Halin, E. Douceron, I. Clerc, C. Journo, N. L. Ko, S. Landry, E. L. Murphy, A. Gessain, I. Lemasson, J.-M. Mesnard, et al. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription Blood, September 17, 2009; 114(12): 2427 - 2438. [Abstract] [Full Text] [PDF] L. Xie, M. Kesic, B. Yamamoto, M. Li, I. Younis, M. D. Lairmore, and P. L. Green Human T-Cell Leukemia Virus Type 2 Rex Carboxy Terminus Is an Inhibitory/Stability Domain That Regulates Rex Functional Activity and Viral Replication J. Virol., May 15, 2009; 83(10): 5232 - 5243. [Abstract] [Full Text] [PDF] M. Li, M. Kesic, H. Yin, L. Yu, and P. L. Green Kinetic Analysis of Human T-Cell Leukemia Virus Type 1 Gene Expression in Cell Culture and Infected Animals J. Virol., April 15, 2009; 83(8): 3788 - 3797. [Abstract] [Full Text] [PDF] T. Zhao, J.-i. Yasunaga, Y. Satou, M. Nakao, M. Takahashi, M. Fujii, and M. Matsuoka Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-{kappa}B Blood, March 19, 2009; 113(12): 2755 - 2764. [Abstract] [Full Text] [PDF] J. Arnold, B. Zimmerman, M. Li, M. D. Lairmore, and P. L. Green Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation Blood, November 1, 2008; 112(9): 3788 - 3797. [Abstract] [Full Text] [PDF] M. Yoshida, Y. Satou, J.-i. Yasunaga, J.-i. Fujisawa, and M. Matsuoka Transcriptional Control of Spliced and Unspliced Human T-Cell Leukemia Virus Type 1 bZIP Factor (HBZ) Gene J. Virol., October 1, 2008; 82(19): 9359 - 9368. [Abstract] [Full Text] [PDF] I. Clerc, N. Polakowski, C. Andre-Arpin, P. Cook, B. Barbeau, J.-M. Mesnard, and I. Lemasson An Interaction between the Human T Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor (HBZ) and the KIX Domain of p300/CBP Contributes to the Down-regulation of Tax-dependent Viral Transcription by HBZ J. Biol. Chem., August 29, 2008; 283(35): 23903 - 23913. [Abstract] [Full Text] [PDF] K. Pichler, T. Kattan, J. Gentzsch, A. K. Kress, G. P. Taylor, C. R. M. Bangham, and R. Grassmann Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein Blood, May 1, 2008; 111(9): 4741 - 4751. [Abstract] [Full Text] [PDF] S. A. Chevalier, M. Walic, S. Calattini, A. Mallet, M.-C. Prevost, A. Gessain, and R. Mahieux Construction and Characterization of a Full-Length Infectious Simian T-Cell Lymphotropic Virus Type 3 Molecular Clone J. Virol., June 15, 2007; 81(12): 6276 - 6285. [Abstract] [Full Text] [PDF] M. Miyazaki, J.-I. Yasunaga, Y. Taniguchi, S. Tamiya, T. Nakahata, and M. Matsuoka Preferential Selection of Human T-Cell Leukemia Virus Type 1 Provirus Lacking the 5' Long Terminal Repeat during Oncogenesis J. Virol., June 1, 2007; 81(11): 5714 - 5723. [Abstract] [Full Text] [PDF] I. Lemasson, M. R. Lewis, N. Polakowski, P. Hivin, M.-H. Cavanagh, S. Thebault, B. Barbeau, J. K. Nyborg, and J.-M. Mesnard Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Protein Interacts with the Cellular Transcription Factor CREB To Inhibit HTLV-1 Transcription J. Virol., February 15, 2007; 81(4): 1543 - 1553. [Abstract] [Full Text] [PDF] J.-M. Mesnard, B. Barbeau, and C. Devaux HBZ, a new important player in the mystery of adult T-cell leukemia Blood, December 15, 2006; 108(13): 3979 - 3982. [Abstract] [Full Text] [PDF] P. Miyazato, J.-i. Yasunaga, Y. Taniguchi, Y. Koyanagi, H. Mitsuya, and M. Matsuoka De Novo Human T-Cell Leukemia Virus Type 1 Infection of Human Lymphocytes in NOD-SCID, Common {gamma}-Chain Knockout Mice J. Virol., November 1, 2006; 80(21): 10683 - 10691. [Abstract] [Full Text] [PDF] S. Calattini, S. A. Chevalier, R. Duprez, P. Afonso, A. Froment, A. Gessain, and R. Mahieux Human T-Cell Lymphotropic Virus Type 3: Complete Nucleotide Sequence and Characterization of the Human Tax3 Protein J. Virol., October 1, 2006; 80(19): 9876 - 9888. [Abstract] [Full Text] [PDF] W. M. Switzer, S. H. Qari, N. D. Wolfe, D. S. Burke, T. M. Folks, and W. Heneine Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis. J. Virol., August 1, 2006; 80(15): 7427 - 7438. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) All Versions of this Article: 2005-11-4551v1 107/10/3976    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Arnold, J. Articles by Green, P. L. Search for Related Content PubMed PubMed Citation Articles by Arnold, J. Articles by Green, P. L. Related Collections Hematopoiesis and Stem Cells Immunobiology Related Article in Blood Online Social Bookmarking                   What's this?

	Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020